Next Biosciences’ group of divisions are involved in the manufacture of biological products, stem cell banking, genetic testing, and other pathology lab testing. Next Biosciences is ISO accredited and licenced by the Department of Health in South Africa. The company believes in a collaborative business approach to ensure that it accesses the best scientific minds and other key players in the industry to deliver our core purpose. Welcome to a World of Next Biosciences. Nothing is inevitable. Anything is possible.
| Website | http://www.nextbio.co.za |
| Revenue | $16.2 million |
| Employees | 87 (64 on RocketReach) |
| Founded | 2005 |
| Technologies | |
| Industry | Biotechnology |
| Keywords | Biotechnology Manufacturing, Clinical Laboratory Services, Pathology Testing Services, Healthcare Laboratory Services, Dna Testing Services, Medical Diagnostics Testing, Molecular Diagnostics, Biopharmaceutical Manufacturing, Regenerative Medicine, Life Science Products, Pharmaceutical Manufacturing, Diagnostic Testing Kits, Stem Cell Research |
| Competitors | CBR, ViaCord, Cryo-Cell, Lifebankusa, Receptos, a wholly-owned subsidiary of Celgene, Smart Cells, Zafgen, Inc., Regenexx Physicians, Angioblast Systems +28 more (view full list) |
Looking for a particular Next Biosciences employee's phone or email?
The Next Biosciences annual revenue was $16.2 million in 2026.
Kim Hulett is the Founder and Chief Executive Officer of Next Biosciences.
64 people are employed at Next Biosciences.
Next Biosciences is based in Midrand, Gauteng.